Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and...
Kandolf Sekulovic, L; Guo, J; Agarwala, S; Hauschild, A; McArthur, G; Cinat, G; Wainstein, A; Caglevic, C; Lorigan, P; Gogas, H; Alvarez, M; Duncombe, R; Lebbe, C; Peris, K; Rutkowski, P; Stratigos, A; Forsea, A-M; De La Cruz Merino, L; Kukushkina, M; Dummer, R; Hoeller, C; Gorry, C; Bastholt, L; Herceg, D; Neyns, B; Vieira, R; Arenberger, P; Bylaite-Bucinskiene, M; Babovic, N; Banjin, M; Putnik, K; Todorovic, V; Kirov, K; Ocvirk, J; Zhukavets, A; Ymeri, A; Stojkovski, I; Garbe, C
2019-10-02 00:00:00
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngEuropean Journal of CancerPubmedhttp://www.deepdyve.com/lp/pubmed/access-to-innovative-medicines-for-metastatic-melanoma-worldwide-04tKqhIW08
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
